RFK's Op-Ed Should Give Biotech Hope -- Market Talk

Dow Jones

2025/03/04

1421 ET - Robert F. Kennedy, Jr.'s latest op-ed on vaccines should give biotechnology companies some hope, Mizuho analysts say. The Secretary of Health and Human Services said in a Sunday opinion piece for Fox News that the latest measles outbreak is a call to action to vaccinate children, which HHS will help facilitate. RFK's pivot to supporting vaccines may mean companies like Vaxcyte that produce them will fare better than investors had worried. Vaxcyte's stock is down 20% over the past three months, primarily driven by political concerns, analysts say. "We continue to believe macro concerns dissipate," analysts said. (katherine.hamilton@wsj.com)

(END) Dow Jones Newswires

March 03, 2025 14:21 ET (19:21 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2516657481"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2516657481\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2516657481?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-04 03:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2516657481","market":"hk","top_or_hot":-1,"title":"RFK's Op-Ed Should Give Biotech Hope -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1421 ET - Robert F. Kennedy, Jr.'s latest op-ed on vaccines should give biotechnology companies some hope, Mizuho analysts say. The Secretary of Health and Human Services said in a Sunday opinion piece for Fox News that the latest measles outbreak is a call to action to vaccinate children, which HHS will help facilitate. RFK's pivot to supporting vaccines may mean companies like Vaxcyte that produce them will fare better than investors had worried. Vaxcyte's stock is down 20% over the past three months, primarily driven by political concerns, analysts say. \"We continue to believe macro concerns dissipate,\" analysts said. (katherine.hamilton@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 03, 2025 14:21 ET (19:21 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RFK's Op-Ed Should Give Biotech Hope -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRFK's Op-Ed Should Give Biotech Hope -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-03-04 03:21</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     1421 ET - Robert F. Kennedy, Jr.'s latest op-ed on vaccines should give biotechnology companies some hope, Mizuho analysts say. The Secretary of Health and Human Services said in a Sunday opinion piece for Fox News that the latest measles outbreak is a call to action to vaccinate children, which HHS will help facilitate. RFK's pivot to supporting vaccines may mean companies like Vaxcyte that produce them will fare better than investors had worried. Vaxcyte's stock is down 20% over the past three months, primarily driven by political concerns, analysts say. \"We continue to believe macro concerns dissipate,\" analysts said. (katherine.hamilton@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 03, 2025 14:21 ET (19:21 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2516657481","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2516657481","pubTimestamp":1741029660,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"1421 ET - Robert F. Kennedy, Jr.'s latest op-ed on vaccines should give biotechnology companies some hope, Mizuho analysts say. The Secretary of Health and Human Services said in a Sunday opinion piece for Fox News that the latest measles outbreak is a call to action to vaccinate children, which HHS will help facilitate. RFK's pivot to supporting vaccines may mean companies like Vaxcyte that produce them will fare better than investors had worried. Vaxcyte's stock is down 20% over the past three months, primarily driven by political concerns, analysts say. \"We continue to believe macro concerns dissipate,\" analysts said. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","IE0009354923.USD":"JANUS HENDERSON US VENTURE \"A2\" (USD) ACC","PCVX":"Vaxcyte, Inc.","LU0053671581.USD":"摩根大通美国小盘成长股 A(dist)","HOPE":"Hope Bancorp, Inc.","BK4211":"区域性银行"},"translate_title":"RFK的专栏文章应该给生物技术带来希望——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HOPE":1,"PCVX":0.9},"content_text":"1421 ET - Robert F. Kennedy, Jr.'s latest op-ed on vaccines should give biotechnology companies some hope, Mizuho analysts say. The Secretary of Health and Human Services said in a Sunday opinion piece for Fox News that the latest measles outbreak is a call to action to vaccinate children, which HHS will help facilitate. RFK's pivot to supporting vaccines may mean companies like Vaxcyte that produce them will fare better than investors had worried. Vaxcyte's stock is down 20% over the past three months, primarily driven by political concerns, analysts say. \"We continue to believe macro concerns dissipate,\" analysts said. (katherine.hamilton@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 03, 2025 14:21 ET (19:21 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}